SOSPES: SPIRIVA® observational study measuring SGRQ score in routine medical practice in Central and Eastern Europe

about

Early impact of treatment with tiotropium, long-acting anticholinergic preparation, in patients with COPD - real-life experience from an observational study.

P2860

Q35208787-91B17B85-BE01-4B85-8322-266F7C37AEFC

P2860

SOSPES: SPIRIVA® observational study measuring SGRQ score in routine medical practice in Central and Eastern Europe

Item

http://www.wikidata.org/entity/Q37249775

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

SOSPES: SPIRIVA® observational ...... in Central and Eastern Europe

@en

SOSPES: SPIRIVA® observational ...... in Central and Eastern Europe.

@nl

type

Item

label

SOSPES: SPIRIVA® observational ...... in Central and Eastern Europe

@en

SOSPES: SPIRIVA® observational ...... in Central and Eastern Europe.

@nl

prefLabel

SOSPES: SPIRIVA® observational ...... in Central and Eastern Europe

@en

SOSPES: SPIRIVA® observational ...... in Central and Eastern Europe.

@nl

P1476

SOSPES: SPIRIVA® observational ...... in Central and Eastern Europe

@en

P2093

Gloria Enache

http://www.w3.org/2001/XMLSchema#string

Goran Martinovic

http://www.w3.org/2001/XMLSchema#string

Matjaž Fležar

http://www.w3.org/2001/XMLSchema#string

Pavla Kadlecová

http://www.w3.org/2001/XMLSchema#string

Peter Kristufek

http://www.w3.org/2001/XMLSchema#string

Sanda Škrinjarić-Cincar

http://www.w3.org/2001/XMLSchema#string

Tatiana Martynenko

http://www.w3.org/2001/XMLSchema#string

P2860

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

Health status measurement in chronic obstructive pulmonary disease.

A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

Health status in the TORCH study of COPD: treatment efficacy and other determinants of change.

Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD

Efficacy and safety of tiotropium in COPD patients in primary care--the SPiRiva Usual CarE (SPRUCE) study.

Primary care physician perceptions on the diagnosis and management of chronic obstructive pulmonary disease in diverse regions of the world.

Correlation of health-related quality of life with other disease severity indices in Indian chronic obstructive pulmonary disease patients

Improvement in self-reported exercise participation with the combination of tiotropium and rehabilitative exercise training in COPD patients.

Effect of tiotropium on health-related quality of life as a primary efficacy endpoint in COPD.

P304

483-492

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/COPD.S45640

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Karina Jahnz-Rózyk

P577

2013-10-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24159258

http://www.w3.org/2001/XMLSchema#string

P932

3806120

http://www.w3.org/2001/XMLSchema#string

SOSPES: SPIRIVA® observational study measuring SGRQ score in routine medical practice in Central and Eastern Europe

about

P2860

P2860

SOSPES: SPIRIVA® observational study measuring SGRQ score in routine medical practice in Central and Eastern Europe

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P932